Abstract:The long-term physiological consequences of SARS-CoV-2, termed Post-Acute Sequelae of COVID-19 (PASC), are rapidly evolving into a major public health concern. The underlying cellular and molecular etiology remain poorly defined but growing evidence links PASC to abnormal immune responses and/or poor organ recovery post-infection. Yet, the precise mechanisms driving non-resolving inflammation and impaired tissue repair in the context of PASC remain unclear. With insights from three independent clinical cohorts of PASC patients with abnormal lung function and/or viral infection-mediated pulmonary fibrosis, we established a clinically relevant mouse model of post-viral lung sequelae to investigate the pathophysiology of respiratory PASC. By employing a combination of spatial transcriptomics and imaging, we identified dysregulated proximal interactions between immune cells and epithelial progenitors unique to the fibroproliferation in respiratory PASC but not acute COVID-19 or idiopathic pulmonary fibrosis (IPF). Specifically, we found a central role for lung-resident CD8+ T cell-macrophage interactions in maintaining Krt8hi transitional and ectopic Krt5+ basal cell progenitors, thus impairing alveolar regeneration and driving fibrotic sequelae after acute viral pneumonia. Mechanistically, CD8+ T cell derived IFN-γ and TNF stimulated lung macrophages to chronically release IL-1β, resulting in the abnormal accumulation of dysplastic epithelial progenitors and fibrosis. Notably, therapeutic neutralization of IFN-γ and TNF, or IL-1β after the resolution of acute infection resulted in markedly improved alveolar regeneration and restoration of pulmonary function. Together, our findings implicate a dysregulated immune-epithelial progenitor niche in driving respiratory PASC. Moreover, in contrast to other approaches requiring early intervention, we highlight therapeutic strategies to rescue fibrotic disease in the aftermath of respiratory viral infections, addressing the current unmet need in the clinical management of PASC and post-viral disease.

IFN-γ and YAP lead epithelial cells astray after severe respiratory infection

Viral infection induces inflammatory signals that coordinate YAP regulation of dysplastic cells in lung alveoli

Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury

Yap/Taz Regulate Alveolar Regeneration and Resolution of Lung Inflammation.

Epithelial plasticity and innate immune activation promote lung tissue remodeling following respiratory viral infection

COVID-19 and influenza infections mediate distinct pulmonary cellular and transcriptomic changes

Epithelial-Mesenchymal Transition Contributes to Pulmonary Fibrosis via Aberrant Epithelial/Fibroblastic Cross-Talk

YAP Alleviates Pulmonary Fibrosis Through Promoting Alveolar Regeneration via Modulating the Stemness of Alveolar Type 2 Cells

An aberrant immune-epithelial progenitor niche drives viral lung sequelae

Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19

Lung structural cell dynamics are altered by influenza virus infection experience leading to rapid immune protection following viral re-challenge

Influenza induces lung lymphangiogenesis independent of YAP/TAZ activity in lymphatic endothelial cells

Exuberant fibroblast activity compromises lung function via ADAMTS4

Airway secretory cell fate conversion via YAP-mTORC1-dependent essential amino acid metabolism

Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis

YAP/TAZ Signaling in the Pathobiology of Pulmonary Fibrosis

The epithelium in idiopathic pulmonary fibrosis: breaking the barrier

Aberrant Transitional Alveolar Epithelial Cells Promote Pathogenic Activation of Lung Fibroblasts in Preclinical Fibrosis Modeling

Influenza A and B Virus-Triggered Epithelial–Mesenchymal Transition Is Relevant to the Binding Ability of NA to Latent TGF-β